141 related articles for article (PubMed ID: 3220617)
21. Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers.
McIlleron H; Norman J; Kanyok TP; Fourie PB; Horton J; Smith PJ
J Antimicrob Chemother; 2007 Dec; 60(6):1398-401. PubMed ID: 17951604
[TBL] [Abstract][Full Text] [Related]
22. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
[TBL] [Abstract][Full Text] [Related]
23. Effect of oral administration of crude aqueous extract of garlic on pharmacokinetic parameters of isoniazid and rifampicin in rabbits.
Dhamija P; Malhotra S; Pandhi P
Pharmacology; 2006; 77(2):100-4. PubMed ID: 16699292
[TBL] [Abstract][Full Text] [Related]
24. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
Titarenko OT; Vakhmistrova TI; Perova TL
Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
[TBL] [Abstract][Full Text] [Related]
25. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
26. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
[TBL] [Abstract][Full Text] [Related]
27. The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
Pillai G; Ellard GA; Smith PJ; Fourie PB
Int J Tuberc Lung Dis; 2001 Aug; 5(8):691-5. PubMed ID: 11495257
[TBL] [Abstract][Full Text] [Related]
28. [The influence of rifampicin upon the metabolism of isoniazid (author's transl)].
Modai J; Coulaud JP; Vivien JM; Berthelot G; Bergogne-Berezin E
Nouv Presse Med; 1978 Apr; 7(15):1263-7. PubMed ID: 662655
[TBL] [Abstract][Full Text] [Related]
29. Drug interaction between rifampicin, isoniazid and cotrimoxazole in rabbits.
Malhi R; Uppal R; Sharma PL
Hum Exp Toxicol; 1992 Mar; 11(2):105-7. PubMed ID: 1349215
[TBL] [Abstract][Full Text] [Related]
30. ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS.
Egelund EF; Isaza R; Alsultan A; Peloquin CA
J Zoo Wildl Med; 2016 Sep; 47(3):868-871. PubMed ID: 27691967
[TBL] [Abstract][Full Text] [Related]
31. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768
[TBL] [Abstract][Full Text] [Related]
32. [The validation of the adequacy of chemotherapy in bladder tuberculosis based on a study of bacteriostatic activity].
Dovlatian AA; Dzhenzhera NA
Probl Tuberk; 1992; (11-12):49-51. PubMed ID: 1289890
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics of isoniazid and rifampicin in an experiment and in clinical practice].
Karkishchenko NN; Khoron'ko VV; Anisimova NB; Vorob'ev VS; Lavrushko AN
Antibiot Khimioter; 1988 Oct; 33(10):786-9. PubMed ID: 3214216
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
Acocella G; Bonollo L; Garimoldi M; Mainardi M; Tenconi LT; Nicolis FB
Gut; 1972 Jan; 13(1):47-53. PubMed ID: 5060669
[TBL] [Abstract][Full Text] [Related]
35. Tuberculosis therapy and enzyme induction in man.
Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
[TBL] [Abstract][Full Text] [Related]
36. Does AIDS impair the absorption of antituberculosis agents?
Taylor B; Smith PJ
Int J Tuberc Lung Dis; 1998 Aug; 2(8):670-5. PubMed ID: 9712282
[TBL] [Abstract][Full Text] [Related]
37. Theophylline pharmacokinetics in well-nourished and malnourished asthmatic children.
Kumar L; Garg SK; Singh S; Lal R; Shukla VK
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):588-92. PubMed ID: 2613392
[TBL] [Abstract][Full Text] [Related]
38. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
Koriakin VA; Sokolova GB; Ziia AV; Zeliger LR; Ivleva AIa
Ter Arkh; 1987; 59(7):75-7. PubMed ID: 3672366
[TBL] [Abstract][Full Text] [Related]
40. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]